1. Steel H, Theron A, Anderson R, Rossouw T. Differential Responsiveness of the Platelet Biomarkers, Systemic CD40 Ligand, CD62P, and Platelet-Derived Growth Factor-BB, to Virally-Suppressive Antiretroviral Therapy. Front Immunol 2021 Jan 29;11:594110. eCollection 2020. [IF 5.085]
  2. Kroeze S, Rossouw TM, Steel HC, Wit FW, Kityo CM, Siwal M et al. Plasma inflammatory biomarkers predict CD4 T-cell recovery and virological rebound in HIV-1 infected Africans on suppressive antiretroviral therapy. J Infect Dis. 2021, 224(4):673–678, [IF 5.022]
  3. Wibmer CK, Ayres F, Hermanus T,  Madzivhandila M,  Kgagudi P, Lambson BE, Vermeulen M, Karin van den Berg, Rossouw T, Boswell M, Ueckermann V, Meiring S, von Gottberg A, Cohen C, Morris L, Bhiman JN, Moore PL. SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma. Nat Med. 2021 Apr;27(4):622-625. doi: 10.1038/s41591-021-01285-x. Epub 2021 Mar 2. PMID: 33654292. [IF 22.660]
  4. Madzime M, Rossouw TM, Theron AJ, Anderson R, Steel HC. Review: Interactions of HIV and antiretroviral therapy with neutrophils and platelets. Frontiers in Immunology 12 March 2021 | [IF 5.085]
  5. Moyo-Gwete T, Madzivhandila M, Makhado Z, Ayres F, Mhlanga D, Oosthuysen B, Lambson BE, Kgagudi P, Tegally H, Iranzadeh A, Doolabh D, Tyers L, Chinhoyi LR, Mennen M, Skelem S, Marais G, Wibmer CK, Bhiman JN, Ueckermann V, Rossouw T, Boswell M, de Oliveira T, Williamson C, Burgers WA, Ntusi N, Morris L, Moore PL. Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351). N Engl J Med 2021; 384:2161-2163DOI: 10.1056/NEJMc2104192. [IF 74.699]
  6. White M, Feucht U, du Toit L, Rossouw T, Connor K. Understanding the impact of maternal HIV infection on the health and well-being of mothers and infants in South Africa: Siyakhula Collaborative Workshop report. Journal of Multidisciplinary Healthcare 2021:14 1987–1999. doi: 10.2147/JMDH.S317829 [IF 1.913]
  7. Rossouw TM, Feldman, C. Editorial: The role of platelet activation in the pathophysiology of HIV, tuberculosis and pneumococcal disease. Front. Immunol., 30 July 2021 | [IF 7.561]
  8. Ngcobo S, Rossouw T. Acceptability of home-based HIV care offered by community health workers in Tshwane district: A survey. AIDS Patient Care STDs. 2022 Feb;36(2):55-63. doi: 10.1089/apc.2021.0216. [IF 5.078]
  9. Rossouw TM, Wassenaar D, Kruger M, Blockman M, Hunter A, Burgess T. Research Ethics Support in COVID-19 Pandemic (RESCOP): a spontaneous collaborative effort by South African research ethics committees. South African Health Review. 2021 Vol 1:163-172.
  10. Richardson SI, Manamela NP, M. Motsoeneng BM, Kaldine H, Ayres F, Makhado Z, Sullivan NJ, Misasi J, Ueckermann V, Rossouw TM, Boswell MT, Ntusi N, Burgers WA, Moore PL.  A SARS-CoV-2 variant of concern triggers Fc effector function with increased cross-reactivity. Cell Reports Medicine, Jan 16, 2022 VOLUME 3, ISSUE 2, 100510, FEBRUARY 15, 2022 . DOI: [New journal]
  11. Rossouw TM, Anderson R, Manga P, Feldman C. Emerging role of vascular endothelium-platelet interactions in the pathogenesis of severe SARS-CoV-2 infection-associated myocardial injury. Front Immunol 2022 Feb 4;13:776861. doi: 10.3389/fimmu.2022.776861. [IF 7.561]
  12. Keeton R, Tinco M, Ngomti A, Baguma R, Benede N, Suzuki A, … Rossouw T, …Burgers W. T cell responses to SARS-CoV-2 spike cross-recognize Omicron. Nature 2022;603(7901):488-492. doi: 10.1038/s41586-022-04460-3. [IF 49.962]
  13. Kitchin D, Richardson SI, van der Mescht MA, Motlou T, Mzindle N, Moyo-Gwete T, Makhado Z, Ayres F, Manamela NP, Spencer H, Lambson B, Oosthuysen B, Kaldine H, du Pisanie M, Mennen M, Skelem S, Williams N, Ntusi NAB, Burgers WA, Gray G, Bekker L-G, Boswell MT, Rossouw TM, Ueckermann V and Moore PL. Ad26.COV2.S breakthrough infections induce high titers of neutralizing antibodies against Omicron and other SARS-CoV-2 variants of concern. Cell Reports Medicine. Volume 3, Issue 3, 15 March 2022, 100535  [New journal]
  14. Ngcobo, S; Scheepers, S; Mbatha, N; Grobler, E; Rossouw, T. Roles, barriers and recommendations for community health workers providing community-based HIV care in sub-Saharan Africa: A systematic, aggregated, narrative review. AIDS Patient Care and STDs. 2022 Apr;36(4):130-144. doi: 10.1089/apc.2022.0020. [IF 5.078]
  15. Richardson SI, Madzorera VS, Spencer H, Manamela NP, van der Mescht MA, Lambson B, Oosthuysen B, Ayres F, Molaudzi Z, Moyo-Gwete T, Mzindle N, Motlou T, Mendes A, Tegally H, Venter M, de Oliviera T, Ueckermann V, Rossouw TM, Boswell MT, Moore PL. SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated individuals. Cell Host Microbe. 2022 Jun 8;30(6):880-886.e4. doi: 10.1016/j.chom.2022.03.29. [IF 21.023].
  16. Roanne Keeton, Marius B. Tincho, Amkele Ngomti, Richard Baguma, Ntombi Benede, Akiko Suzuki, Khadija Khan, Sandile Cele, Mallory Bernstein, Farina Karim, Sharon V. Madzorera, Thandeka Moyo-Gwete, Mathilda Mennen, Sango Skelem, Marguerite Adriaanse, Daniel Mutithu, Olukayode Aremu, Cari Stek, Elsa du Bruyn, Mieke A. Van Der Mescht, Zelda de Beer, Talita R. de Villiers, Annie Bodenstein, Gretha van den Berg, Adriano Mendes, Amy Strydom, Marietjie Venter, Jennifer Giandhari, Yeshnee Naidoo, Sureshnee Pillay, Houriiyah Tegally, Alba Grifoni, Daniela Weiskopf, Alessandro Sette, Robert J. Wilkinson, Tulio de Oliveira, Linda-Gail Bekker, Glenda Gray, Veronica Ueckermann, Theresa Rossouw, Michael T. Boswell, Jinal N. Bhiman, Penny L. Moore, Alex Sigal, Ntobeko A. B. Ntusi, Wendy A. Burgers & Catherine Riou. T cell responses to SARS-CoV-2 spike cross-recognize Omicron. Nature. 2022 Mar 17;603(7901):488-92.
  17. Richardson SI, Madzorera VS, Spencer H, Manamela NP, van der Mescht MA, Lambson BE, Oosthuysen B, Ayres F, Makhado Z, Moyo-Gwete T, Mzindle N. SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated, individuals. Cell host & microbe. 2022 Jun 8;30(6):880-6.
  18. Loveday M, Goga A, Dhai A, Labuschaigne M, Rossouw T, Burgess T, Blockman M, Wallace M, Strode A, Daniels B, Spooner E, Bekker L-G. Ethically acceptable consent approaches to adolescent research in South Africa. Southern African Journal of HIV Medicine 2022, 23(1):a1385 DOI: [IF 2.744]
  19. Worsley CM, van der Mescht MA, Hoffman D, Meyer PWA, Ueckermann V, Rossouw TM. Decline in antibody responses to SARS-CoV-2 post-vaccination poses a risk to health care workers. Journal of Infection 2022 Jun 12;S0163-4453(22)00360-7. doi: 10.1016/j.jinf.2022.06.008.  [IF 6.072]
  20. Rossouw TM & Makhalanyane TP. Editorial comment: Dysbiosis and immune dysregulation: distilling the evidence. AIDS [In press]. [IF 4.177]
  21. Ncgobo S, Olorunju S, Nkwenika T, Rossouw TM. Effect of a ward-based outreach team and adherence game intervention on retention in care and virological suppression of HIV-infected patients newly initiated on antiretroviral treatment in Tshwane, South Africa. Southern African Journal of HIV Medicine [In press] [IF 2.75].
  22. Moyo-Gwete T, Madzivhandila M, Mkhize NN, Kgagudi P, Ayres F, Lambson BE, Manamela NP, Richardson SI, Makhado Z, van der Mescht M, de Beer Z, de Villiers TR, Burgers WA, Ntusi N, Rossouw T, Ueckermann V, Boswell M, Moore PL. Shared N417-dependent epitope on the SARS-CoV-2 Omicron, Beta and Delta-plus variants. J Virol 2022 Aug 10;96(15):e0055822. doi: 10.1128/jvi.00558-22. Epub 2022 Jul 13. [IF 4.501]
  23. Madzime M, Theron AJ, Anderson R, Tintinger GR, Steel HC, Meyer PWA, Feldman C, Rossouw TM. Dolutegravir potentiates platelet activation by a calcium-dependent, ionophore-like mechanism. Journal of Immunotoxicology, 19:1, 1-8, DOI: 10.1080/1547691X.2022.2142705. [IF 2.054]
  24. Simone I. Richardson; Thopisang Motlou; Mieke A. van der Mescht; Bronwen E. Lambson; Josie Everatt; Daniel Gyamfi Amoako; Anne von Gottberg; Nicole Wolter; Zelda de Beer; Talita Roma de Villiers; Annie Bodenstein; Gretha van den Berg; Theresa M. Rossouw; Michael T. Boswell; Veronica Ueckermann; Jinal N. Bhiman; Penny Moore. SARS-CoV-2 BA.4 infection triggers more cross-reactive neutralizing antibodies than BA.1. Cell Host & Microbe 2022 Jun 8; 30(6): 880–886.e4. [IF 31.32]
  25. Annette J. Theron, Ronald Anderson, Morris Madzime, Theresa M. Rossouw, Helen C. Steel, Pieter W.A. Meyer, Cholo M.C., Luyanda L. I. Kwofie, Charles Feldman, Gregory R. Tintinger. Pro-inflammatory interactions of dolutegravir with human neutrophils in vitro. Molecules 2022, 27, 9057.   [IF 4.947]
  26. Louise D. V. du Toit, Andrea Prinsloo, Helen C. Steel, Ute Feucht, Theresa M. Rossouw. Immune and metabolic alterations in children with perinatal HIV exposure. Viruses 2023, 15(2), 279; [IF 5.818]
  27. W van Staden, A Nienaber, T Rossouw, A Turner, C Filmater, AE Mercier, JG Nel, S Bapela, MM Beetge, R Blumenthal, CDV Castelyn, TW de Witt, AG Dlagnekova, C Kotze, JS Mangwane, L Napoles, R Sommers, L Sykes, WB van Zyl, M Venter, A Uys, N Warren. Race in health research: considerations for researchers and research ethics committees. S Afr J Bioethics Law April 2023: 9-12
  28. Shayne Mason, Mari van Reenen, Theresa Rossouw, Zander Lindeque, Roan Louw. Phenylalanine metabolism and tetrahydrobiopterin bio-availability in COVID-19 and HIV. Heliyon 2023, 9(4): e15010, [IF 2.85]
  29. Richardson SI, Kgagudi P, Manamela NP, Kaldine H, Venter EM, Pillay T, Lambson BE, van der Mescht MA, Hermanus T, Balla SR, de Beer Z, de Villiers TR, Bodenstein A, van den Berg G, du Pisanie M, Burgers WA, Ntusi NAB, Abdullah F, Ueckermann V, Rossouw TM, Boswell MT, Moore PL. Antibody-dependent cellular cytotoxicity against SARS-CoV-2 Omicron sub-lineages is reduced in convalescent sera regardless of infecting variant. Cell Reports Medicine. 2023 Jan 17;4(1).
  30. 30 Motsoeneng BM, Manamela NP, Kaldine H, Kgagudi P, Hermanus T, Ayres F, Makhado Z, Moyo-Gwete T, Van Der Mescht MA, Abdullah F, Boswell MT. Despite delayed kinetics, people living with HIV achieve equivalent antibody function after SARS-CoV-2 infection or vaccination. Frontiers in Immunology.;14:1231276.
  31. Mieke A. van der Mescht, Zelda de Beer, Helen C. Steel, Fareed Abdullah, Veronica Ueckermann, Ronald Anderson, Theresa M. Rossouw. Comparison of platelet- and endothelial-associated biomarkers of disease activity in hospitalized COVID-19 patients with and without HIV co-infection. Frontiers in Immunology.
  32. Thulani P. Makhalanyane, Oliver K.I. Bezuidt, Rian E. Pierneef, Eshchar Mizrachi, Adolphe Zeze, Romain K. Fossou, Claude Ghislaine Kouadjo, Sam Duodu, Chioma B. Chikere, Olubukola O. Babalola, Ashwil Klein, Marshall Keyster, Mornè du Plessis, Nourou S. Yorou, Mohamed Hijri, Theresa Rossouw, Casper N. Kamutando, Stephanus Venter, Lucy N. Moleleki, and Colin Murrell. African microbiomes matter. Nature Reviews Microbiology.

List of manuscripts under review in journals:

  1. Kroeze S, Kootstra NA, van Nuenen C, Rossouw TM, Kityo CM, Siwale M, Akanmu S, Mandaliya K, de Jager M, Ondoa P, Wit FW, Peter Reiss, Tobias F. Rinke de Wit, Raph L. Hamers. Specific plasma microRNAs are associated with HIV infection and CD4+ T-cell recovery during suppressive antiretroviral therapy. AIDS.
  2. Boitumelo M Motsoeneng, Nelia P Manamela, Haajira Kaldine, Prudence Kgagudi, Tandile Hermanus, Frances Ayres, Zanele Makhado, Thandeka Moyo-Gwete, Mieke A Van Der Mescht, Fareed Abdullah, Michael T Boswell, Veronica Ueckermann, Theresa Marié Rossouw, Shabir Madhi, Penny Moore and Simone I Richardson. Despite delayed kinetics, people living with HIV achieve equivalent antibody function after SARS-CoV-2 infection or vaccination Frontiers in Immunology, section Viral Immunology.




Copyright © University of Pretoria 2024. All rights reserved.

FAQ's Email Us Virtual Campus Share Cookie Preferences